ACCELERON PHARMA INC - COMMON STOCK (XLRN)

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class
Equity / COMMON STOCK
Total 13F shares
20,868,859
Share change
+3,598,750
Total reported value
$708,920,517
Put/Call ratio
8.3%
Price per share
$33.97
Number of holders
91
Value change
+$122,086,996
Number of buys
66
Number of sells
33

Institutional Holders of ACCELERON PHARMA INC - COMMON STOCK (XLRN) as of Q2 2014

As of 30 Jun 2014, ACCELERON PHARMA INC - COMMON STOCK (XLRN) was held by 91 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,868,859 shares. The largest 10 holders included FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, Polaris Venture Management Co IV LLC, ADAGE CAPITAL PARTNERS GP LLC, QVT Financial LP, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, Sectoral Asset Management Inc, State Street Corp, and JPMORGAN CHASE & CO. This page lists 91 institutional shareholders reporting positions in this security for the Q2 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.